The legal soundness of the United States’ cannabis rescheduling process came under renewed scrutiny on Sunday as fresh analysis argued that the post-Chevron regulatory landscape may expose the DEA’s scheduling procedures to constitutional challenge. Separately, Tennessee confirmed a 1 July enforcement date for its THCA ban, Robinhood extended cannabis stock access following federal rescheduling, researchers identified CBD as a viable industrial plastic, and a Canadian medical operator posted near-doubled insured revenue.
The procedural foundations of the DEA’s cannabis scheduling approach may be more vulnerable than assumed, according to a legal analysis published by The Marijuana Herald. University of Oklahoma law student Anthony Deininger argues that the Supreme Court’s Loper Bright ruling removed the Chevron deference courts previously extended to the DEA’s interpretation of the Controlled Substances Act. The agency can no longer unilaterally determine that section 811(a)(2) requires formal rulemaking, he contends, proposing a Hybrid model as more constitutionally defensible. The analysis raises questions about the June 29 administrative hearing, which must conclude by 15 July and will determine whether recreational cannabis is reclassified alongside medical products in Schedule III. Multiple lawsuits already target the April rescheduling order; procedural weaknesses could give opponents additional grounds to litigate. See the cannabis rescheduling hub for ongoing developments.
Tennessee will ban the sale of THCA and other intoxicating hemp-derived products from 1 July under rules finalised by the state’s Alcoholic Beverage Commission, Marijuana Moment reported. The commission assumed full regulatory authority over hemp in January and confirmed the enforcement date after a transitional grace period permitted existing THCA retailers to continue operating until 30 June. Industry estimates suggest roughly 75% of Tennessee hemp sales derive from THCA, and state tax revenue forecasts for the sector have fallen from $55 million to under $10 million annually. The rules implement legislation passed by the state general assembly in 2025 and represent one of the most consequential state-level moves against intoxicating hemp cannabinoids as the federal November 2026 product deadline approaches.
Retail investors can now trade major US cannabis multistate operators on Robinhood following the federal rescheduling of medical cannabis to Schedule III in April, Yahoo Finance reported, with Green Thumb Industries and Curaleaf among the first plant-touching companies added to the platform. The development coincides with Robinhood securing Canadian regulatory approval to acquire WonderFi Technologies, extending its reach into Canadian crypto services. Uplisting to mainstream US exchanges such as the NYSE or Nasdaq remains unlikely before the DEA’s June 29 hearing concludes. Analysts flagged Robinhood’s valuation as stretched at roughly 105% above estimated fair value, noting the platform’s fortunes are increasingly tied to regulatory conditions in both cannabis and crypto markets. Follow sector performance on the cannabis stocks tracker.
A hemp-derived plastic synthesised from CBD can stretch to 16 times its original length and withstand boiling temperatures better than existing plant-based alternatives, according to research from the University of Connecticut covered by Marijuana Moment. Chemist Gregory Sotzing described the material’s heat stability as unmatched among natural-resource plastics; it is also chemically recyclable and degrades without microplastic residue. Published in the journal Chem Circularity, the findings are being cited by sustainable packaging advocates in the cannabis sector, where plastic waste has become a live regulatory pressure point in several US states. Broader commercial adoption would require substantial expansion of hemp cultivation to generate sufficient CBD feedstock.
Canadian cannabis e-commerce operator Herbal Dispatch (CSE: HERB) reported that direct-to-consumer medical revenue rose 98% year-on-year to $761,375 in the first quarter of 2026, driven by insured veterans whose annual per-patient spending averages around $6,000, the company said in results published on Newsfilecorp. The platform is onboarding roughly 50 new insured patients each month and operates five proprietary brands across more than 40 product lines. International medical shipments totalled approximately 1,321 kilograms since the start of 2026, predominantly to Germany and Australia, through an EU-GMP certified supply chain. Chief executive Philip Campbell cited AI-enabled automation as central to margin improvement plans. For wider corporate developments see the cannabis M&A tracker.
The week ahead is dominated by preparations for the DEA’s June 29 administrative hearing, the first formal test of whether the US rescheduling process can survive legal challenge. Tennessee’s July 1 THCA enforcement date also looms for transitional retailers.
The post Cannabis News Today — Sunday 1 June 2026: Rescheduling under legal strain as Tennessee confirms THCA deadline appeared first on Business of Cannabis.
Continue reading...
Federal rescheduling process faces fresh legal questions in post-Chevron era
The procedural foundations of the DEA’s cannabis scheduling approach may be more vulnerable than assumed, according to a legal analysis published by The Marijuana Herald. University of Oklahoma law student Anthony Deininger argues that the Supreme Court’s Loper Bright ruling removed the Chevron deference courts previously extended to the DEA’s interpretation of the Controlled Substances Act. The agency can no longer unilaterally determine that section 811(a)(2) requires formal rulemaking, he contends, proposing a Hybrid model as more constitutionally defensible. The analysis raises questions about the June 29 administrative hearing, which must conclude by 15 July and will determine whether recreational cannabis is reclassified alongside medical products in Schedule III. Multiple lawsuits already target the April rescheduling order; procedural weaknesses could give opponents additional grounds to litigate. See the cannabis rescheduling hub for ongoing developments.
Tennessee confirms July THCA ban as state hemp tax projections collapse
Tennessee will ban the sale of THCA and other intoxicating hemp-derived products from 1 July under rules finalised by the state’s Alcoholic Beverage Commission, Marijuana Moment reported. The commission assumed full regulatory authority over hemp in January and confirmed the enforcement date after a transitional grace period permitted existing THCA retailers to continue operating until 30 June. Industry estimates suggest roughly 75% of Tennessee hemp sales derive from THCA, and state tax revenue forecasts for the sector have fallen from $55 million to under $10 million annually. The rules implement legislation passed by the state general assembly in 2025 and represent one of the most consequential state-level moves against intoxicating hemp cannabinoids as the federal November 2026 product deadline approaches.
Robinhood widens US cannabis stock access as WonderFi deal adds Canadian scale
Retail investors can now trade major US cannabis multistate operators on Robinhood following the federal rescheduling of medical cannabis to Schedule III in April, Yahoo Finance reported, with Green Thumb Industries and Curaleaf among the first plant-touching companies added to the platform. The development coincides with Robinhood securing Canadian regulatory approval to acquire WonderFi Technologies, extending its reach into Canadian crypto services. Uplisting to mainstream US exchanges such as the NYSE or Nasdaq remains unlikely before the DEA’s June 29 hearing concludes. Analysts flagged Robinhood’s valuation as stretched at roughly 105% above estimated fair value, noting the platform’s fortunes are increasingly tied to regulatory conditions in both cannabis and crypto markets. Follow sector performance on the cannabis stocks tracker.
CBD-derived thermoplastic outperforms conventional materials in heat and stretch tests
A hemp-derived plastic synthesised from CBD can stretch to 16 times its original length and withstand boiling temperatures better than existing plant-based alternatives, according to research from the University of Connecticut covered by Marijuana Moment. Chemist Gregory Sotzing described the material’s heat stability as unmatched among natural-resource plastics; it is also chemically recyclable and degrades without microplastic residue. Published in the journal Chem Circularity, the findings are being cited by sustainable packaging advocates in the cannabis sector, where plastic waste has become a live regulatory pressure point in several US states. Broader commercial adoption would require substantial expansion of hemp cultivation to generate sufficient CBD feedstock.
Herbal Dispatch posts near-doubled insured medical revenue on veteran and export growth
Canadian cannabis e-commerce operator Herbal Dispatch (CSE: HERB) reported that direct-to-consumer medical revenue rose 98% year-on-year to $761,375 in the first quarter of 2026, driven by insured veterans whose annual per-patient spending averages around $6,000, the company said in results published on Newsfilecorp. The platform is onboarding roughly 50 new insured patients each month and operates five proprietary brands across more than 40 product lines. International medical shipments totalled approximately 1,321 kilograms since the start of 2026, predominantly to Germany and Australia, through an EU-GMP certified supply chain. Chief executive Philip Campbell cited AI-enabled automation as central to margin improvement plans. For wider corporate developments see the cannabis M&A tracker.
The week ahead is dominated by preparations for the DEA’s June 29 administrative hearing, the first formal test of whether the US rescheduling process can survive legal challenge. Tennessee’s July 1 THCA enforcement date also looms for transitional retailers.
The post Cannabis News Today — Sunday 1 June 2026: Rescheduling under legal strain as Tennessee confirms THCA deadline appeared first on Business of Cannabis.
Continue reading...
